摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-iodo-3,4-dimethyl-1-nitrobenzene | 909135-23-5

中文名称
——
中文别名
——
英文名称
2-iodo-3,4-dimethyl-1-nitrobenzene
英文别名
3-iodo-1,2-dimethyl-4-nitrobenzene
2-iodo-3,4-dimethyl-1-nitrobenzene化学式
CAS
909135-23-5
化学式
C8H8INO2
mdl
——
分子量
277.062
InChiKey
YJEXTEWJBCPDAZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    45.8
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-iodo-3,4-dimethyl-1-nitrobenzenepotassium phosphate 、 palladium on activated charcoal 、 氢气 、 palladium diacetate 、 potassium carbonate对甲苯磺酸4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下, 以 1,4-二氧六环N-甲基吡咯烷酮甲醇N,N-二甲基甲酰胺 为溶剂, 反应 28.0h, 生成 (6-((5-chloro-2-((2-methoxy-5-(1-methyl-1H-pyrazol-4-yl)-4-(4-(2,7-diazaspiro[3.5]nonyl-7-yl))phenyl)amino)pyrimidin-4-yl)amino)-2,3-dimethylphenyl)phosphine oxide
    参考文献:
    名称:
    EGFR Inhibitor, Composition, and Preparation Method Therefor
    摘要:
    本发明涉及公式I的化合物,使用该化合物作为EGFR抑制剂的方法,以及包含这些化合物的药物组合物。这些化合物可用于治疗、预防或改善癌症或感染等疾病或疾病。
    公开号:
    US20220259235A1
  • 作为产物:
    描述:
    参考文献:
    名称:
    使用苯胺作为掩蔽的交叉偶联伙伴:伸缩三步流重氮化,碘化二重氮化,交叉偶联工艺的设计
    摘要:
    通过使用伸缩的三反应器流动重氮化/碘化重氮化/交叉偶联工艺,可以将市售苯胺转化为联芳基和联芳基乙炔产品。通过使用由内部定制软件控制的特别设计的连续流装置,将在桑德梅尔序列中由除气产生的分段流动流恢复到反应溶液的连续塔中。然后将生成的芳基碘化物与交叉偶联溶液流合并,将其送入最终反应器中。该系统被证明是通用的,因为可以快速进行重氮化/碘化重氮化序列的修饰,以考虑到任何底物特异性(例如,溶解性问题),从而导致了Suzuki–Miyaura和Sonogashira交叉偶联产物的广泛底物范围。
    DOI:
    10.1002/chem.201603626
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Asymmetric Ring-Opening of Cyclic Diaryliodonium with Benzylic and Aliphatic Amines
    作者:Shibo Xu、Kun Zhao、Zhenhua Gu
    DOI:10.1002/adsc.201800637
    日期:2018.10.18
    A Cu‐catalyzed asymmetric ringopening reaction between cyclic diaryliodonium and benzylic or aliphatic amines has been developed. At low concentration of the amines, realized by either mixing the amines with Lewis acid or slow addition of the amines, the reaction afforded the products in high enantioselectivity.
    已开发出环状二芳基鎓与苄基或脂肪族胺之间的Cu催化不对称开环反应。在低浓度的胺下,通过将胺与路易斯酸混合或缓慢加入胺来实现,该反应提供了高对映选择性的产物。
  • Enhanced Reactivity by Torsional Strain of Cyclic Diaryliodonium in Cu-Catalyzed Enantioselective Ring-Opening Reaction
    作者:Kun Zhao、Longhui Duan、Shibo Xu、Julong Jiang、Yao Fu、Zhenhua Gu
    DOI:10.1016/j.chempr.2018.01.017
    日期:2018.3
    asymmetric ring-opening amination reaction of cyclic diaryliodoniums. Increasing the torsional strain of these cyclic compounds significantly improved the reactivity of cyclic diaryliodoniums. Computational investigation indicated that the two conformers of the cyclic diaryliodoniums had a low rotational barrier, and generally the reaction achieved high yields and high enantioselectivity (up to >99%
    阻转异构体是由于绕单键旋转受限而产生的立体异构体。特别地,联芳基阻转异构体代表一类重要的化合物,因为它们广泛存在于天然产物配体和药物分子中。然而,在温和条件下制备结构多样的联芳基阻转异构体是一项重大挑战。在这里,我们描述了一个-双(恶唑啉基)吡啶催化的环状二芳基鎓的不对称开环胺化反应。增加这些环状化合物的扭转应变可显着提高环状二芳基鎓的反应性。计算研究表明,环状二芳基鎓的两个构象异构体具有较低的旋转势垒,并且通常该反应实现了高收率和高对映选择性(高达> 99%ee)。此外,与涉及二芳基鎓的传统反应相比,这种开环胺化反应还具有较高的原子经济性。最后,我们提出了一个催化循环和一个机制模型,用于解释所观察到的对映选择性。
  • A Versatile Method for Kinetic Resolution of Protecting‐Group‐Free BINAMs and NOBINs through Chiral Phosphoric Acid Catalyzed Triazane Formation
    作者:Wei Liu、Qianwen Jiang、Xiaoyu Yang
    DOI:10.1002/anie.202009395
    日期:2020.12.21
    azodicarboxylates. A series of mono‐N‐protected and unprotected BINAMs, diphenyl diamines and NOBIN derivatives could be kinetically resolved with excellent performances (with s factor up to 420). The gram‐scale reactions and facile derivatizations of the chiral products demonstrate the potential of these methods in the asymmetric synthesis of chiral catalysts and ligands.
    通过手性磷酸与偶氮二羧酸酯催化三氮烷的形成,已实现了无保护基的BINAM和NOBIN的通用动力学拆分。一系列具有单-N-保护和未保护的BINAM,二苯二胺和NOBIN衍生物可以动力学拆分,并具有出色的性能(系数高达420)。手性产物的克级反应和易衍生化证明了这些方法在手性催化剂和配体的不对称合成中的潜力。
  • OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF
    申请人:Maruoka Keiji
    公开号:US20100041881A1
    公开(公告)日:2010-02-18
    An optically active quaternary ammonium salt compound represented by formula ( 1 ), wherein R 1 represents a halogen, a C 1-8 alkyl which is optionally substituted and which is linear, branched, or cyclic, a C 2-8 alkenyl which is optionally substituted, a C 2-8 alkynyl which is optionally substituted, a C 6-14 aryl which is optionally substituted, a C 3-8 heteroaryl which is optionally substituted, a C 1-8 alkoxy which is optionally substituted and which is linear, branched, or cyclic, or a C 7-16 aralkyl which is optionally substituted; R 2 and R 21 each independently represents hydrogen, halogen, nitro, a C 1-8 alkyl which is optionally substituted and which is linear, branched, or cyclic, a C 2-8 alkenyl which is optionally substituted, a C 2-8 alkynyl which is optionally substituted, a C 6-14 aryl which is optionally substituted, a C 1-8 alkoxy which is optionally substituted and which is linear, branched, or cyclic, or a C 7-16 aralkyl which is optionally substituted; one of combinations of R 1 and R 21 , and R 2 and R 21 , may bond to form a C 1-6 alkylene which is optionally substituted, a C 1-6 alkylenemonooxy which is optionally substituted, or a C 1-6 alkylenedioxy which is optionally substituted; R 3 and R 4 each independently represents hydrogen, a C 6-14 aryl which is optionally substituted, a C 3-8 heteroaryl which is optionally substituted, or a C 7-16 aralkyl which is optionally substituted, with a proviso that R 3 and R 4 are not hydrogen at the same time; R 5 represents hydrogen, halogen, a C 1-8 alkyl which is optionally substituted and which is linear, branched, or cyclic, a C 1-8 alkoxy which is optionally substituted and which is linear, branched, or cyclic, a C 2-8 alkenyl which is optionally substituted, or a C 2-8 alkynyl which is optionally substituted; R 6 represents halogen, a C 1-8 alkyl which is optionally substituted and which is linear, branched, or cyclic, a C 1-8 alkoxy which is optionally substituted and which is linear, branched, or cyclic, a C 2-8 alkenyl which is optionally substituted, or a C 2-8 alkynyl which is optionally substituted, and R 5 and R 6 may bond to form an aromatic ring which is optionally substituted; ring A and ring B do not have a same substituent at the same time; symbols * and ** represent an optical activity having an axial chirality; and X −1 represents an anion.
    一种光学活性的季盐化合物,其化学式表示为(1),其中R1代表卤素,C1-8烷基(可选择性取代,线性、支链或环状),C2-8烯基(可选择性取代),C2-8炔基(可选择性取代),C6-14芳基(可选择性取代),C3-8杂环芳基(可选择性取代),C1-8烷氧基(可选择性取代,线性、支链或环状)或C7-16芳基烷基(可选择性取代);R2和R21各自独立地表示氢,卤素,硝基,C1-8烷基(可选择性取代,线性、支链或环状),C2-8烯基(可选择性取代),C2-8炔基(可选择性取代),C6-14芳基(可选择性取代),C1-8烷氧基(可选择性取代,线性、支链或环状)或C7-16芳基烷基(可选择性取代);R1和R21的组合之一,以及R2和R21的组合之一,可以结合形成C1-6烷基(可选择性取代),C1-6烷基单氧(可选择性取代)或C1-6烷基二氧(可选择性取代);R3和R4各自独立地表示氢,C6-14芳基(可选择性取代),C3-8杂环芳基(可选择性取代)或C7-16芳基烷基(可选择性取代),但R3和R4不能同时为氢;R5表示氢,卤素,C1-8烷基(可选择性取代,线性、支链或环状),C1-8烷氧基(可选择性取代,线性、支链或环状),C2-8烯基(可选择性取代)或C2-8炔基(可选择性取代);R6表示卤素,C1-8烷基(可选择性取代,线性、支链或环状),C1-8烷氧基(可选择性取代,线性、支链或环状),C2-8烯基(可选择性取代)或C2-8炔基(可选择性取代),且R5和R6可以结合形成一个芳环(可选择性取代);环A和环B在同一时间不具有相同的取代基;符号*和**表示轴手性的光学活性;X^-1表示阴离子。
  • Optically active ammonium salt compound, production intermediate thereof, and production method thereof
    申请人:Maruoka Keiji
    公开号:US08367820B2
    公开(公告)日:2013-02-05
    Disclosed is an optically active quaternary ammonium salt compound represented by the formula (1) below. Also disclosed are a production intermediate of such an optically active quaternary ammonium salt compound, and a method for producing such an optically active quaternary ammonium salt compound. (1) (In the formula, R1, R2, R21, R3 and R4 respectively represent an alkyl group, an aryl group or the like; R5 and R6 respectively represent an alkyl group, an alkoxy group or the like; and X− represents an anion.)
    本发明揭示了一种光学活性的季盐化合物,其化学式如下所示(1)。本发明还揭示了这种光学活性季盐化合物的制备中间体以及制备这种光学活性季盐化合物的方法。(在式中,R1、R2、R21、R3和R4分别表示烷基、芳基或类似物;R5和R6分别表示烷基、烷氧基或类似物;X-表示阴离子。)
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫